Page 95 - Annual Report

Young Researcher Award
During 2020-21, the Trust invited online applications Dr. R. Mahalakshmi has a long-standing track record
from leading scientific research institutions within of accomplishments in scientific pursuits and has
the country and also advertised the Award in a established a high quality externally funded
leading Indian scientific journal and newspapers in independent research programme at IISER Bhopal
four zones. A total of 40 projects were received. The in the areas of membrane biology and protein
members of the Indian Scientific Advisory structure. She proposes to leverage these strengths
Committee (ISAC), comprising Dr. Surekha. M. towards a potentially new class of treatment for
Zingde, Prof. Susheel Durani, Dr. Tester Ashavaid, Dr. tuberculosis, with a clear research plan that is both
Anurag Agrawal and Dr. Shobhona Sharma feasible and ambitious.
shortlisted 3 applicants for an interview and finally
recommended Dr. Radhakrishnan Mahalakshmi of Institutional Research Grants for Acute Leukemia
the Indian Institute of Science Education and The focus for the year 2020-21 was to consider
Research, Bhopal for the Young Researcher Award – Institutional Research Grant support for ACUTE
2020 for her project entitled “Functional tagging of LEUKEMIA. Of the 12 proposals received, 3 multi-year
a Mycobacterial chaperone towards projects were approved.
next-generation antibiotics”.

Name Institute Name Project Title
Dr. Nikhil Patkar ACTREC, Tata Memorial Centre, Metagenomics (mNGS) for the rapid identification of pathogenic organisms
Mumbai. causing sepsis in adult patients of acute leukemia (AL) including those
undergoing bone marrow transplantation (BMT).

Dr. Vivek S Radhakrishnan Tata Medical Center, Kolkata Integrating comprehensive immune characterization to multi-modal genomics
and microbiome strategy in acute myeloid leukemia to better inform disease
management.

Dr. Arun Kumar Trivedi CSIR-Central Drug Research Institute. Deciphering FLT3-ITD elicited signaling pathways in AML cell growth and block in
Lucknow differentiation: Hunt for therapeutic targets and inhibitors for mutant FLT3
proteins.

ANNUAL REPORT 2020-21 88